The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

FDA Removes Use Limitation for Yescarta in Main CNS Lymphoma

The U.S. Meals and Drug Administration (FDA) has authorized an replace to the prescribing info for Yescarta (axicabtagene ciloleucel), eradicating earlier limitations...

Why Is Lung Well being Key to Survivorship After Most cancers Remedy?

In an interview with CURE, Dr. Joshua Sabari, a thoracic medical oncologist at NYU Langone Well being’s Perlmutter Most cancers Middle and...

KTX-1001 Elicits Responses in Some With A number of Myeloma

The investigational oral remedy KTX-1001, often known as gintemetostat, is catching curiosity as a possible therapy for a subgroup of sufferers with...

Biomarker-Free Relacorilant Combo Broadens Choices in Ovarian Most cancers

Therapy with relacorilant plus Abraxane (nab-paclitaxel) could provide a broader choice for sufferers with platinum-resistant ovarian most cancers as a result of...

Professional Insights into Advances in Gastrointestinal Most cancers Therapy

Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medication on the Cleveland Clinic...

Hot Topics